Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Feasibility of the MyokinE100 System in ICU Settings to Mitigate ICU Acquired Weakness

NCT07362862 is registered in ClinicalTrials.gov with Health Discovery Labs as lead sponsor.

NCT NCT07362862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07362862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Feasibility of the MyokinE100 System in ICU Settings to Mitigate ICU Acquired Weakness
Lead sponsor
Health Discovery Labs
Phase
Not applicable
Overall status
Recruiting
Start date
May 5, 2026
Completion date
August 31, 2027
Enrollment
50 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness, icu-acquired muscle weakness, icu-acquired weakness, icuaw, sarcopenia, secondary sarcopenia, sepsis